About Enhancer
| Enhancer ID: | E_01_0481 |
| Species: | human |
| Position : | chr20:22578409-22580409   |
| Biosample name: | |
| Experiment class : | High+Lowthroughput |
| Enhancer type: | Enhancer |
| Disease: | Liver metastasis, primary hepatocellular carcinoma, decompensated cirrhosis |
| Pubmed ID: | 29761173 |
| Enhancer experiment: | qRT-PCR,immunohistochemistry |
| Enhancer experiment description: | HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. |
About Target gene
| Target gene : | OTC,CYP3A4,F7,LRP1 |
| Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: | RNA-Seq |
| Target gene experiment description: | HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. |
About TF
| TF name : | FOXA2(HNF3B,TCF3B) |
| TF experiment: | qRT-PCR,immunohistochemistry |
| TF experiment description: | HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. ;HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. |
About Function
| Enhancer function : | HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. |
| Enhancer function experiment: | Immunohistochemical staining |
| Enhancer function experiment description: |
HNF4? and other members of the LETFs appear to be important regulators of hepatocyte function in patients with chronic hepatic failure. |
About SNP
| SNP ID: | -- |
Upstream Pathway Annotation of TF
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| FOXA2 | FOXA1 transcription factor network | pid | 45 |
| FOXA2 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
| FOXA2 | Hedgehog signaling events mediated by Gli proteins | pid | 49 |
| FOXA2 | Regulation of gene expression in beta cells | reactome | 17 |
| FOXA2 | Maturity onset diabetes of the young | kegg | 25 |
| FOXA2 | Hs_Endoderm_Differentiation_WP2853_88152 | wikipathways | 62 |
| FOXA2 | Hs_Dopaminergic_Neurogenesis_WP2855_87239 | wikipathways | 19 |
| FOXA2 | Hs_Heart_Development_WP1591_90186 | wikipathways | 28 |
| FOXA2 | Hs_Ectoderm_Differentiation_WP2858_89329 | wikipathways | 56 |
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene